Journal of Medicinal Chemistry p. 4401 - 4410 (2019)
Update date:2022-08-05
Topics:
Riggs, Jennifer R.
Elsner, Jan
Cashion, Dan
Robinson, Dale
Tehrani, Lida
Nagy, Mark
Fultz, Kimberly E.
Krishna Narla, Rama
Peng, Xiaohui
Tran, Tam
Kulkarni, Ashutosh
Bahmanyar, Sogole
Condroski, Kevin
Pagarigan, Barbra
Fenalti, Gustavo
Lebrun, Laurie
Leftheris, Katerina
Zhu, Dan
Boylan, John F.
Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. P
View MoreXinxiang Junlong Biological Technology Co., Ltd.
website:https://junlongbio.lookchem.com/
Contact:86-13525059581
Address:Xinxiang City, Henan Province
Contact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Suzhou HeChuang Chemical Co.,Ltd.
Contact:+86-512-88800520
Address:No.9 Guanchao Rd,Changshu Advanced Materials Industy Park
Anhui Gusheng Import&Export CO.,LTD
Contact:86-551-63662296
Address:Jinzhai Road NO.162 ,hefei, china
website:http://www.antaibio.com
Contact:86-21-60939051,60939771
Address:Room 2108, Building 2,No. 489 Zhengli Road,200433
Doi:10.1021/ol503655a
(2015)Doi:10.3987/com-02-9607
(2003)Doi:10.1016/S0022-328X(00)83682-7
(1974)Doi:10.1248/cpb.22.2004
(1974)Doi:10.1021/jo00896a027
(1975)Doi:10.1021/ja01559a069
(1957)